![](/img/cover-not-exists.png)
Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome: Primary Results of the DISPERSE-2 Trial
Christopher P. Cannon, Steen Husted, Robert A. Harrington, Benjamin M. Scirica, Håkan Emanuelsson, Gary Peters, Robert F. StoreyVolume:
50
Year:
2007
Language:
english
DOI:
10.1016/j.jacc.2007.07.053
File:
PDF, 215 KB
english, 2007